The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue cancer with a survival rate below 27% for high-risk children despite aggressive multi-modal therapeutic interventions. After decades of research, no targeted therapies are currently available. Therapeutically targeting actin-binding pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelison, Robert, Marrah, Laine, Fierti, Adelaide, Piczak, Claire, Glowczyk, Martyna, Tajammal, Anam, Lynch, Sarah, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531751/
https://www.ncbi.nlm.nih.gov/pubmed/37762498
http://dx.doi.org/10.3390/ijms241814196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531751/
https://www.ncbi.nlm.nih.gov/pubmed/37762498
http://dx.doi.org/10.3390/ijms241814196

Ejemplares similares